NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $2,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 431,475 | $15,433,000 | 5.92% |
| SECTORAL ASSET MANAGEMENT INC | 1,623,073 | $58,057,000 | 2.60% |
| Palo Alto Investors LP | 1,190,263 | $42,576,000 | 2.50% |
| Fiera Capital (Europe) Ltd. | 426,250 | $3,246,000 | 2.39% |
| BENDER ROBERT & ASSOCIATES | 75,080 | $2,686,000 | 1.76% |
| FCG ADVISORS, LLC | 76,865 | $3,138,000 | 1.55% |
| Penn Capital Management Company, LLC | 857,621 | $30,677,000 | 1.29% |
| NEXT CENTURY GROWTH INVESTORS LLC | 927,285 | $33,168,000 | 1.20% |
| Tekla Capital Management LLC | 625,900 | $22,388,000 | 1.05% |
| Orbimed Advisors | 2,954,900 | $105,697,000 | 1.01% |